切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2021, Vol. 10 ›› Issue (01) : 6 -10. doi: 10.3877/cma.j.issn.2095-3259.2021.01.002

所属专题: 文献

专家论坛

妊娠期糖尿病筛查的方法及评价
许煌坊1, 李笑天1,()   
  1. 1. 200011 上海,复旦大学附属妇产科医院 上海市女性生殖内分泌相关疾病重点实验室 上海市生物医学科学研究所
  • 收稿日期:2020-12-01 出版日期:2021-02-18
  • 通信作者: 李笑天
  • 基金资助:
    国家"十三五"规划重大项目(2016YFC1000400); 国家重点基础研究发展规划(973计划)(2015CB943300); 上海市临床科技创新重点项目(18511105602); 上海市女性生殖疾病重点临床医学中心(2017ZZ01016)

Screening methods and evaluation of gestational diabetes mellitus

Huangfang Xu1, Xiaotian Li1()   

  • Received:2020-12-01 Published:2021-02-18
  • Corresponding author: Xiaotian Li
引用本文:

许煌坊, 李笑天. 妊娠期糖尿病筛查的方法及评价[J]. 中华产科急救电子杂志, 2021, 10(01): 6-10.

Huangfang Xu, Xiaotian Li. Screening methods and evaluation of gestational diabetes mellitus[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2021, 10(01): 6-10.

妊娠期糖尿病(gestational diabetes mellitus, GDM)是影响妊娠结局的主要危险因素之一,与母儿近、远期不良妊娠结局密切相关。近年来,随着人们生活水平的提升和饮食习惯的改变,GDM的发病率呈现逐年增长的趋势,且越来越年轻化,及时筛查并给予有效的干预与治疗措施是降低GDM发病率及减少妊娠期相关并发症的关键。本文就不同的GDM的筛查策略进行综合分析,为改善母婴结局提供选择。

Gestational diabetes mellitus (GDM) is one of the main risk factors affecting pregnancy outcomes, which is closely related to the adverse pregnancy outcomes of mothers and infants in the near and long term. In recent years, with the improvement of living standards and changes in dietary habits, the incidence rate of GDM has been increasing year by year, and is becoming younger. Timely screening and effective intervention and treatments are the key to decrease the incidence rate of GDM and reduce the complications during pregnancy. In this paper, different screening strategies for GDM is comprehensively analyzed to provide options for improving maternal and infant outcomes.

[1]
Zhang XQ, Xiao YS. The Association Between Trimester-Specific Weight Gain and Severe Preeclampsia/Adverse Perinatal Outcome in Gestational Diabetes Mellitus Complicated by Preeclampsia: A Retrospective Case Study [J]. Diabetes Ther, 2019, 10(2): 725-734.
[2]
Catalano PM, McIntyre HD, Cruickshank JK, et al. HAPO Study Cooperative Research Group. The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes [J]. Diabetes Care, 2012, 35(4): 780-786.
[3]
Nguyen-Ngo C, Jayabalan N, Salomon C, et al. Molecular pathways disrupted by gestational diabetes mellitus[J]. J Mol Endocrinol, 2019, 63(3): R51-R72.
[4]
Zhu WW, Yang HX, Wei YM, et al. Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in china[J]. Diabetes Care, 2013, 36(3): 586-590.
[5]
Consensus Development Panel. National Institutes of Health consensus development conference statement: diagnosing gestational diabetes mellitus, March 4-6, 2013 [J]. Obstet Gynecol, 2013, 122(2 Pt 1): 358-369.
[6]
Aaron B, Caughey MT. ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus [J]. Obstet Gynecol, 2018, 131(2): e49-e64.
[7]
Sovio U, Murphy HR, Smith GC. Accelerated Fetal Growth Prior to Diagnosis of Gestational Diabetes Mellitus: A Prospective Cohort Study of Nulliparous Women [J]. Diabetes Care, 2016, 39(6): 982-987.
[8]
Moyer VA, Preventive Services Task Force. Screening for gestational diabetes mellitus: U. S. Preventive Services Task Force recommendation statement[J]. Ann Intern Med, 2014, 160(6): 414-420.
[9]
Landon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes [J]. N Engl J Med, 2009, 361(14): 1339-1348.
[10]
Palatnik A, Mele L, Landon MB, et al. Timing of treatment initiation for mild gestational diabetes mellitus and perinatal outcomes [J]. Am J Obstet Gynecol, 2015, 213(4): 560.e1-8.
[11]
American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018[J]. Diabetes Care, 2018, 41(Suppl 1): S13-S27.
[12]
Lowe WL, Lowe LP, Kuang A, et al. Maternal glucose levels during pregnancy and childhood adiposity in the Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study [J]. Diabetologia, 2019, 62(4): 598-610.
[13]
谢幸,苟文丽.妇产科学 [M].8版. 北京:人民卫生出版社,2013:76-77.
[14]
Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes [J]. Am J Obstet Gynecol, 1982, 144(7): 768-773.
[15]
Lanni S, Barrett D. The predictive value of the 1-h 50-g glucose screen for diagnosing gestational diabetes mellitus in a high-risk population [J]. J Matern Fetal Neonatal Med, 2004, 15(6): 375-379.
[16]
Cheng YW, Esakoff TF, Block-Kurbisch I, et al. Screening or diagnostic: Markedly elevated glucose loading test and perinatal outcomes [J]. J Matern Fetal Neonatal Med, 2006, 19(11): 729-734.
[17]
Temming LA TM, Stout MJ, Macones GA, et al. Diagnostic Ability of Elevated 1-hour Glucose Challenge Test[J]. J Perinatol, 2016, 36(5): 342-346.
[18]
Van Leeuwen M, Louwerse MD, Opmeer BC, et al. Glucose challenge test for detecting gestational diabetes mellitus: a systematic review [J]. BJOG, 2012, 119(4): 393-401.
[19]
Roeckner JT, Sanchez-Ramos L, Jijon-Knupp R, et al. Single abnormal value on 3-hour oral glucose tolerance test during pregnancy is associated with adverse maternal and neonatal outcomes: a systematic review and metaanalysis [J]. Am J Obstet Gynecol, 2016, 215(3): 287-297.
[20]
Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes [J]. N Engl J Med, 2005, 352(24): 2477-286.
[21]
Saccone G, Caissutti C, Khalifeh A, et al. One step versus two step approach for gestational diabetes screening: systematic review and meta-analysis of the randomized trials[J]. J Matern Fetal Neonatal Med, 2019, 32(9): 1547-1555.
[22]
Caissutti C, Khalifeh A, Saccone G, et al. Are women positive for the One Step but negative for the Two Step screening tests for gestational diabetes at higher risk for adverse outcomes [J]. Acta Obstet Gynecol Scand, 2018, 97(2): 122-134.
[23]
Bonis C, Lorenzini F, Bertrand M, et al. Glucose Profiles in Pregnant Women After a Gastric Bypass: Findings from Continuous Glucose Monitoring [J]. Obes Surg, 2016, 26(9): 2150-2155.
[24]
Yu F, Lv L, Liang Z, et al. Continuous glucose monitoring effects on maternal glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus: a prospective cohort study [J]. J Clin Endocrinol Metab, 2014, 99(12): 4674-4682.
[25]
Yu Q, Aris IM, Tan KH, et al. Application and Utility of Continuous Glucose Monitoring in Pregnancy: A Systematic Review[J]. Front Endocrinol (Lausanne), 2019, 10: 697.
[26]
Saeedi M, Hanson U, Simmons D, et al. Characteristics of different risk factors and fasting plasma glucose for identifying GDM when using IADPSG criteria: a cross-sectional study [J]. BMC Pregnancy Childbirth, 2018, 18(1): 225.
[27]
d′Emden M, McLeod D, Ungerer J, et al. Development of a fasting blood glucose-based strategy to diagnose women with gestational diabetes mellitus at increased risk of adverse outcomes in a COVID-19 environment [J]. PLoS One, 2020, 15(12): e0243192.
[28]
Zawiejska A, Wróblewska-Seniuk K, Gutaj P, et al. Early Screening for Gestational Diabetes Using IADPSG Criteria May Be a Useful Predictor for Congenital Anomalies: Preliminary Data from a High-Risk Population [J]. J Clin Med, 2020, 9(11): 3553.
[29]
Shao B, Mo M, Xin X, et al. The interaction between prepregnancy BMI and gestational vitamin D deficiency on the risk of gestational diabetes mellitus subtypes with elevated fasting blood glucose [J]. Clin Nutr, 2020, 39(7): 2265-2273.
[30]
Sacks DA, Chen W, Wolde-Tsadik G, et al. Fasting plasma glucose test at the first prenatal visit as a screen for gestational diabetes [J]. Obstet Gynecol, 2003, 101(6): 1197-1203.
[31]
Hinkle SN, Tsai MY, Rawal S, et al. HbA1c Measured in the First Trimester of Pregnancy and the Association with Gestational Diabetes [J]. Sci Rep, 2018, 8(1): 12249.
[32]
Mendes N, Alves M, Andrade R, et al. Association between glycated albumin, fructosamine, and HbA1c with neonatal outcomes in a prospective cohort of women with gestational diabetes mellitus [J]. Int J Gynaecol Obstet, 2019, 146(3): 326-332.
[33]
Lai Y, Chen H, Du Z, et al. The diagnostic accuracy of HbA1c in detecting gestational diabetes mellitus among Chinese pregnant individuals [J]. Ann Transl Med, 2020, 8(16): 1014.
[34]
Agarwal MM, Punnose J, Dhatt GS. Gestational diabetes: problems associated with the oral glucose tolerance test [J]. Diabetes Res Clin Pract, 2004, 63(1): 73-74.
[35]
Schwartz JG, Phillips WT, Blumhardt MR, et al. Use of a more physiologic oral glucose solution during screening for gestational diabetes mellitus [J]. Am J Obstet Gynecol, 1994, 171(3): 685-691.
[36]
McIntyre HD. Discovery, Knowledge, and Action-Diabetes in Pregnancy Across the Translational Spectrum: The 2016 Norbert Freinkel Award Lecture [J]. Diabetes Care, 2018, 41(2): 227-232.
[37]
Zawiejska A, Wróblewska-Seniuk K, Gutaj P, et al. Early Screening for Gestational Diabetes Using IADPSG Criteria May Be a Useful Predictor for Congenital Anomalies: Preliminary Data from a High-Risk Population [J]. J Clin Med, 2020, 9(11): 3553.
[38]
Eriksen NB, Damm P, Mathiesen ER, et al. The prevalence of congenital malformations is still higher in pregnant women with pregestational diabetes despite near-normal HbA1c: a literature review [J]. J Matern Fetal Neonatal Med, 2019, 32(8): 1225-1229.
[39]
Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy [J]. Diabetes Care, 2010, 33(3): 676-682.
[40]
Zhang CC, Yang YX, Chen RY, et al. Aberrant expression of oxidative stress related proteins affects the pregnancy outcome of gestational diabetes mellitus patients [J]. Am J Transl Res, 2019, 11(1): 269-279.
[41]
Wang J, Chen K, Jin X, et al. Prognostic factors for cesarean section outcome of pregnant women with gestational diabetes mellitus: a systematic review and meta-analysis [J]. Diabetes Metab Syndr Obes, 2019, 12: 913-929.
[42]
Yang W, Liu J, Li J, et al. Interactive effects of prepregnancy overweight and gestational diabetes on macrosomia and large for gestational age: A population-based prospective cohort in Tianjin, China [J]. Diabetes Res Clin Pract, 2019, 154: 82-89.
[43]
Kuo CH, Li HY. Diagnostic Strategies for Gestational Diabetes Mellitus: Review of Current Evidence [J]. Curr Diab Rep, 2019, 19(12): 155.
[1] 旺久, 陈军, 朱霞, 米玛央金, 赵胜, 陈欣林, 李建华, 王双. 山南市妇幼保健院开展胎儿系统超声筛查的效果分析[J]. 中华医学超声杂志(电子版), 2023, 20(07): 728-733.
[2] 李辉, 吴奇, 张子琦, 张晗, 王仿, 许鹏. 日间全膝关节置换术早期疗效及标准化流程探索[J]. 中华关节外科杂志(电子版), 2023, 17(06): 889-892.
[3] 王璐, 樊杨. 子宫内膜癌相关生物标志物研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 511-516.
[4] 危玲, 李会, 陈奕. 孕产妇产超广谱β-内酰胺酶的肠杆菌定植/感染与母婴传播研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 517-521.
[5] 杨皓媛, 龚杰, 邹青伟, 阮航. 哮喘孕妇的母婴不良妊娠结局研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 522-529.
[6] 陈甜甜, 王晓东, 余海燕. 双胎妊娠合并Gitelman综合征孕妇的妊娠结局及文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 559-568.
[7] 居晓庆, 金蕴洁, 王晓燕. 剖宫产术后瘢痕子宫患者再次妊娠阴道分娩发生子宫破裂的影响因素分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 575-581.
[8] 顾娟, 孙擎擎, 胡方方, 曹义娟, 祁玉娟. 子宫内膜容受性检测改善胚胎反复种植失败患者妊娠结局的临床应用[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 582-587.
[9] 陈絮, 詹玉茹, 王纯华. 孕妇ABO血型联合甲状腺功能检测对预测妊娠期糖尿病的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 604-610.
[10] 周梦玲, 薛志伟, 周淑. 妊娠合并子宫肌瘤的孕期变化及其与不良妊娠结局的关系[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 611-615.
[11] 李晓阳, 刘柏隆, 周祥福. 大数据及人工智能对女性盆底功能障碍性疾病的诊断及风险预测[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 549-552.
[12] 李小娟, 李炜佳, 彭凌燕, 周鹏莹, 李桂娥, 刘相辰. 体检人群中前列腺钙化灶的检出率及临床特征分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 336-338.
[13] 顾娇娇, 邹燕, 陈奕辰, 黄师菊, 张慧玲, 林楠. 基于简易营养评价精法评估肝癌患者出院后营养状况及其影响因素[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 534-539.
[14] 李美娜, 宋艳丽, 杨姗姗, 李聚彩, 罗慧利, 吕杰. 三联预康复策略在退行性脊柱侧弯患者围术期的应用效果[J]. 中华老年骨科与康复电子杂志, 2023, 09(06): 356-364.
[15] 张郁妍, 胡滨, 张伟红, 徐楣, 朱慧, 羊馨玥, 刘海玲. 妊娠中期心血管超声参数与肝功能的相关性及对不良妊娠结局的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 499-504.
阅读次数
全文


摘要